EntryPoint Capital’s Centessa Pharmaceuticals CNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,651
Closed -$218K 761
2024
Q3
$218K Buy
13,651
+5,515
+68% +$88.2K 0.12% 412
2024
Q2
$73.5K Sell
8,136
-1,500
-16% -$13.5K 0.11% 433
2024
Q1
$109K Buy
+9,636
New +$109K 0.1% 373